Nationally Recognized Cancer Researchers Join Gibbs Cancer Center & Research Institute
Two physicians joined the Gibbs Cancer Center & Research Institute team in February, adding to the excellent cancer care provided by Spartanburg Regional Healthcare System. Gibbs Cancer Center & Research Institute has a long record of performing clinical trials through the NCI Community Cancer Centers Program. Caio Rocha Lima, M.D., and Melanie Thomas, M.D., joined the team to expand and grow clinical trial offerings to pharmaceutical industry trials and bring cutting-edge trials to the Upstate with their experience and knowledge in cancer care. Gibbs is providing access to regional and national clinical trials to patients; keeping their care local. These clinical trials play a major role in in the fight against cancer and will eventually save many lives.
Clinical trials are not available at most community hospitals and cancer patients have to travel to distant academic cancer centers. However, Gibbs is working to bring these trials to the Upstate community. Thomas and Rocha Lima will play a large role in making these clinical trial opportunities available to our patients.
Caio Rocha Lima, M.D. – Rocha Lima will serve as Medical Director for Medical Oncology and Associate Center Director for Translational Research at the Gibbs Cancer Center & Research Institute. He received his medical degree and completed his residency in Brazil. Rocha Lima received his fellowship in hematology oncology from the Medical University of South Carolina in Charleston, S.C. He was an assistant professor of medicine at Moffitt Cancer Center in Tampa, Fla., and professor of medicine at University of Miami. Rocha Lima has special interests in gastrointestinal and thoracic oncology. He was a program leader at University of Miami in gastrointestinal and drug development in oncology. Rocha Lima is a member of the American College of Physicians, American Society of Clinical Oncology, American Association of Cancer Research, European Society of Medical Oncology, Cancer and Leukemia Group B and Eastern Oncology Cooperative Group. He is board certified in oncology and internal medicine, and he is fluent in English, Portuguese and Spanish.
Melanie B. Thomas, M.D. – Thomas will serve as the Associate Center Director for Experimental Therapeutics at the Gibbs Cancer Center & Research Institute. She received her medical degree from Boston University School of Medicine in Boston, Mass. She completed her internship and residency at Beth Israel Deaconess Medical Center at Harvard Medical School. Thomas completed her medical oncology fellowship training at The University of Texas MD Anderson Cancer Center. She was the Associate Director of Clinical Investigations at Hollings Cancer Center, Associate Professor, Division of Hematology-Oncology and Grace E. DeWolff Chair in GI Oncology, Department of Medicine at the Medical University of South Carolina prior to joining Gibbs. Thomas has special interests in clinical research, gastrointestinal malignancy, specifically liver, bile duct and gallbladder cancers. She is board certified in internal medicine and medical oncology. Thomas has led numerous clinical trials for patients with liver and other gastrointestinal cancers and is recognized nationally and internationally as an expert in these malignancies.
About Gibbs Cancer Center & Research Institute
Gibbs Cancer Center & Research Institute is a nationally recognized cancer treatment and research facility associated with the National Cancer Institute Community Cancer Center program, the Medical University of South Carolina and the MD Anderson Cancer Network. Named for benefactors Marsha and Jimmy Gibbs and with locations in Spartanburg, Gaffney and Greer, Gibbs is a proven leader in providing effective cancer treatment through advanced technology, professional expertise and an exceptional level of personalized care. Gibbs’ oncology program, which also includes the Bearden-Josey Center for Breast Health, has been recognized by the Commission on Cancer of the American College of Surgeons as offering high-quality cancer care. In 2012, Gibbs joined forces with Bon Secours St. Francis Health System to expand world-class oncology services and clinical research in the Upstate. In 2013, the Gibbs expanded its research efforts by opening a 7,500-square-foot state-of-the-art facility at Pelham Medical Center.
About Spartanburg Regional Healthcare System
Featuring a full spectrum of services, Spartanburg Regional Healthcare System (SRHS) is comprised of three hospitals, outpatient surgery centers, a multi-disciplinary physician group, a vibrant post-acute division, and is home to Gibbs Cancer Center & Research Institute. With more than 300 physicians and 5,900 associates on staff, SRHS serves 11 counties in South and North Carolina. Spartanburg Medical Center was ranked No. 1 regional hospital in South Carolina by U.S. News and World Report; the Gibbs Cancer Center & Research Institute received the Outstanding Achievement Award from the Commission on Cancer; and the American Nurses Association lists SRHS among the nation’s top seven percent of hospitals for excellence in nursing.